TY - JOUR
T1 - Expression of α-smooth muscle actin in benign or malignant ovarian tumors
AU - Kobayashi, Hiroaki
AU - Tsuruchi, Nobuhiro
AU - Sugihara, Koichiro
AU - Kaku, Tsunehisa
AU - Saito, Toshiaki
AU - Kamura, Toshiharu
AU - Tsukamoto, Naoki
AU - Nakano, Hitoo
AU - Taniguchi, Shunicihro
N1 - Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 1993/3
Y1 - 1993/3
N2 - We compared the expression of α-smooth muscle actin (α-SMA) between benign and malignant human ovarian tissues by immunohistochemical staining and Western blot analysis using the monoclonal antibody specific to α-SMA. In normal human ovaries, α-SMA was found in the blood vessel walls, muscle fibers, and stromal cells surrounding the follicles. The main source of α- SMA in the benign ovarian tumors was the blood vessel walls which highly expressed the α-SMA throughout the tumor. In malignant tumor tissues, however, the vessels located in or close to the cluster of cancer cells did not express α-SMA. It corresponded to the results of the Western blot analysis, showing that the amount of α-SMA in malignant ovarian tumor tissues was much smaller than that in benign tumor tissues. Thus, the alteration in α-SMA expression seems to reflect the qualitative difference in vessels between benign and malignant ovarian tissues, and therefore α- SMA is considered to potentially be a histopathologically useful marker for indicating the malignant potential of ovarian tumors.
AB - We compared the expression of α-smooth muscle actin (α-SMA) between benign and malignant human ovarian tissues by immunohistochemical staining and Western blot analysis using the monoclonal antibody specific to α-SMA. In normal human ovaries, α-SMA was found in the blood vessel walls, muscle fibers, and stromal cells surrounding the follicles. The main source of α- SMA in the benign ovarian tumors was the blood vessel walls which highly expressed the α-SMA throughout the tumor. In malignant tumor tissues, however, the vessels located in or close to the cluster of cancer cells did not express α-SMA. It corresponded to the results of the Western blot analysis, showing that the amount of α-SMA in malignant ovarian tumor tissues was much smaller than that in benign tumor tissues. Thus, the alteration in α-SMA expression seems to reflect the qualitative difference in vessels between benign and malignant ovarian tissues, and therefore α- SMA is considered to potentially be a histopathologically useful marker for indicating the malignant potential of ovarian tumors.
UR - http://www.scopus.com/inward/record.url?scp=0027537936&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027537936&partnerID=8YFLogxK
U2 - 10.1006/gyno.1993.1054
DO - 10.1006/gyno.1993.1054
M3 - Article
C2 - 8462899
AN - SCOPUS:0027537936
SN - 0090-8258
VL - 48
SP - 308
EP - 313
JO - Gynecologic Oncology
JF - Gynecologic Oncology
IS - 3
ER -